NewLink Genetics Corp (NASDAQ:NLNK)

4.73
Delayed Data
As of Apr 26
 +0.14 / +3.05%
Today’s Change
3.75
Today|||52-Week Range
19.47
-41.68%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close4.59
Today’s open4.61
Day’s range4.56 - 4.76
Volume409,242
Average volume (3 months)1,057,803
Market cap$291.7M
Data as of 4:00pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+21.77%
Earnings growth (this year)-2.32%
Earnings growth (next 5 years)+14.35%
Revenue growth (last year)-19.73%
P/E ratioNM
Price/Sales8.84
Price/Book1.92

Competitors

 Today’s
change
Today’s
% change
OBSVObseva SA-0.34-2.68%
ATHXAthersys Inc-0.02-1.00%
NYMXNymox Pharmaceutical...-0.05-1.18%
KURAKura Oncology Inc+0.75+5.07%
Data as of 4:00pm ET, 04/26/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$28.7M
Annual profit (last year)-$72.0M
Net profit margin-250.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Director
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts